Kymera Therapeutics (KYMR) PT Lowered to $53 at Stifel
Tweet
Share
E-mailGet Alerts KYMR Hot Sheet
Price: $114.42 +0.34%
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Stifel analyst Bradley Canino lowered the price target on Kymera Therapeutics (NASDAQ: KYMR) to $53.00 (from $55.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- Lenovo Group Ltd. (992:HK) (LNVGY) PT Raised to HK$66 at Macquarie
- Jubilant Foodworks Ltd (JUBI:IN) PT Raised to INR520 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
